Topic: drug manufacturing
Sanofi will close a plant in France with 50 employees and has pledged to address pollution issues there.
Zhejiang Huahai Pharmaceutical informed the EMA that it had identified a chemical that might lead to cancer in its valsartan provided to the European market.
Foshan Jinxiong Technology has been on an import alert list since February, banning all of its products from entering the U.S.
The University of Strathclyde is joining a partnership backing the new $74 million Medicines Manufacturing Innovation Center.
FDA inspectors found that AbbVie didn’t include historical death complaints for the same lot in its search system for its all-too-important drug Humira.
Sun Pharma, India's largest drug manufacturer, said pricing pressure in its generics market targeting the U.S. may lead to lower 2019 revenues.
Astellas plots 600 job cuts in Japan; GSK's infectious disease lead launches a Chinese biotech; Sun Pharma's Zytiga rival wins the FDA's blessing.
Gilead has opened its new $11 million manufacturing facility control lab in Ireland.
South Korea's PRP has acquires a 6,000 meter plant that can produce 2 million vials of the generic ingredient used in wrinkle fighter Botox.
Aspen Pharmacare is expanding into complex meds for cancer and other conditions and has opened an $80 million facility that can produce them.